These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23123541)

  • 1. Life-threatening complications of ibogaine: three case reports.
    Paling FP; Andrews LM; Valk GD; Blom HJ
    Neth J Med; 2012 Nov; 70(9):422-4. PubMed ID: 23123541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias.
    Grogan J; Gerona R; Snow JW; Kao L
    J Emerg Med; 2019 Oct; 57(4):e99-e104. PubMed ID: 31630892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibogaine related sudden death: a case report.
    Papadodima SA; Dona A; Evaggelakos CI; Goutas N; Athanaselis SA
    J Forensic Leg Med; 2013 Oct; 20(7):809-11. PubMed ID: 24112325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of QT Prolongation and Torsades de Pointes Caused by Ibogaine Toxicity.
    Hildyard C; Macklin P; Prendergast B; Bashir Y
    J Emerg Med; 2016 Feb; 50(2):e83-7. PubMed ID: 26329675
    [No Abstract]   [Full Text] [Related]  

  • 5. Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review.
    Maciulaitis R; Kontrimaviciute V; Bressolle FM; Briedis V
    Hum Exp Toxicol; 2008 Mar; 27(3):181-94. PubMed ID: 18650249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga.
    Paškulin R; Jamnik P; Danevčič T; Koželj G; Krašovec R; Krstić-Milošević D; Blagojević D; Strukelj B
    J Ethnopharmacol; 2012 Aug; 143(1):319-24. PubMed ID: 22751004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ibogaine - structure, influence on human body, clinical relevance].
    Zdrojewicz Z; Kuszczak B; Olszak N
    Pol Merkur Lekarski; 2016 Jul; 41(241):50-55. PubMed ID: 27734823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatalities temporally associated with the ingestion of ibogaine.
    Alper KR; Stajić M; Gill JR
    J Forensic Sci; 2012 Mar; 57(2):398-412. PubMed ID: 22268458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication development of ibogaine as a pharmacotherapy for drug dependence.
    Mash DC; Kovera CA; Buck BE; Norenberg MD; Shapshak P; Hearn WL; Sanchez-Ramos J
    Ann N Y Acad Sci; 1998 May; 844():274-92. PubMed ID: 9668685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibogaine for treating drug dependence. What is a safe dose?
    Schep LJ; Slaughter RJ; Galea S; Newcombe D
    Drug Alcohol Depend; 2016 Sep; 166():1-5. PubMed ID: 27426011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
    Lengyel C; Várkonyi T; Fazekas T
    Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-addiction drug ibogaine and the heart: a delicate relation.
    Koenig X; Hilber K
    Molecules; 2015 Jan; 20(2):2208-28. PubMed ID: 25642835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How toxic is ibogaine?
    Litjens RP; Brunt TM
    Clin Toxicol (Phila); 2016; 54(4):297-302. PubMed ID: 26807959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibogaine in the treatment of substance dependence.
    Brown TK
    Curr Drug Abuse Rev; 2013 Mar; 6(1):3-16. PubMed ID: 23627782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of anesthesia on cardiac repolarization.
    Owczuk R; Wujtewicz MA; Zienciuk-Krajka A; Lasińska-Kowara M; Piankowski A; Wujtewicz M
    Minerva Anestesiol; 2012 Apr; 78(4):483-95. PubMed ID: 22318402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk.
    Koenig X; Kovar M; Boehm S; Sandtner W; Hilber K
    Addict Biol; 2014 Mar; 19(2):237-239. PubMed ID: 22458604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures.
    Mash DC; Kovera CA; Pablo J; Tyndale RF; Ervin FD; Williams IC; Singleton EG; Mayor M
    Ann N Y Acad Sci; 2000 Sep; 914():394-401. PubMed ID: 11085338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymorph ventricular tachycardia with torsades de pointes caused by administration of terodiline (Mictrol)].
    van der Klauw MM; van Rey FJ; Stricker BH
    Ned Tijdschr Geneeskd; 1992 Jan; 136(2):91-3. PubMed ID: 1370730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-QT syndrome induced by the antiaddiction drug ibogaine.
    Hoelen DW; Spiering W; Valk GD
    N Engl J Med; 2009 Jan; 360(3):308-9. PubMed ID: 19144953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.